Product Description
The global hip arthroscopy market was valued at just over $450 million in 2025. This is expected to increase over the forecast period at a CAGR of 6.3% to reach almost $700 million by 2032.
The full report suite on the global market for hip arthroscopy includes radiofrequency probes, banana blades, hip access kits, suture anchors and disposable kits.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Hip Arthroscopy Market Trends
The global hip arthroscopy market faces significant disparities in professional expertise. While North America and Western Europe have established specialized training hubs, less developed markets in the Asia-Pacific region, Latin America and Africa continue to face a substantial lack of accessible training and guidance. In these regions, the high cost of arthroscopic towers and specialized instrumentation is compounded by a scarcity of fellowship-trained surgeons who can manage the steep learning curve associated with the hip’s complex anatomy. While international societies have launched traveling fellowships in 2025 to bridge this gap, the lack of local mentorship remains a primary restraint on the widespread adoption of hip preservation in emerging economies.
Global Hip Arthroscopy Market Share Insights
- Arthrex remains the market leader in 2025 by prioritizing all-suture technology and integrated access. The Knotless Hip FiberTak® anchor is the primary driver because it provides high-strength fixation with a bone-preserving footprint. This is supported by the SwiftStitch™ suture passer which utilizes a low-profile 1.5 mm design for easier maneuvering. For procedural efficiency, the company offers the Hip Arthroscopy Master Disposable Kit which bundles CapsuleCut™ banana blades and atraumatic cannulas. In the radiofrequency segment, the MP90™ and XL90™ probes provide precise tissue management within the constrained joint space.
- Stryker maintains the second-leading position by focusing on all-suture platforms and streamlined instrumentation. The Iconix® Knotless anchor is the company’s biggest driver because it minimizes bone removal while ensuring stable labral repair. This is often paired with the Pivot Complete Hip Kit which integrates nitinol guidewires and the Pivot Samurai Blade® to speed up joint access. For tissue resection, the Serfas® XL Energy probes and CrossFire® 2 console remain core products due to their stable ablation and real-time monitoring. The company also utilizes preprocessed allografts to simplify complex labral reconstructions in outpatient settings.
- Smith & Nephew holds a strong third-leading share by offering specialized solutions for patient safety and joint preservation. The Q-FIX® KNOTLESS anchor is a major driver due to its best-in-class fixation and tensioning capabilities. For joint entry, the Pink Hip Kit™ has become a standard for postless distraction which reduces the risk of nerve complications. The WEREWOLF® FLOW 90® COBLATION® wand is the leading radiofrequency probe in 2026 because its AMBIENT® technology monitors temperatures to protect surrounding cartilage. Additionally, the use of REGENESORB® material in its MICRORAPTOR® anchors supports long-term biological healing and bone replacement.
Global Hip Arthroscopy Market Segmentation Summary
- Radiofrequency Probe Market – Further Segmented Into:
- Modular Type: Articulating and Static Radiofrequency Probes.
- Banana Blade Market
- Hip Access Kit Market
- Suture Anchor Market
- Disposable Kit Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
